These findings suggest that ADSCs exert their therapeutic effects in RA joints by enhancing stem cell differentiation, upregulating factors involved in immune regulation, and enhancing cell adhesion to interact more effectively with CX3CR1+ macrophages. Here, CX3CR1 is linked to rheumatoid arthritis.